EYECHEQ INC. — SEC Form D Filing
EYECHEQ INC. filed an SEC Form D on June 25, 2026, reporting $9.95M raised in Health Technology.
Form D filing details
- Filing
- SEC Form D
- Filing date
- June 25, 2026
- Amount reported
- $9.95M
- Industry
- Health Technology
- Website
- https://www.eyecheq.com/
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
A significant number of patients, particularly those with diabetes, are not receiving the necessary diabetic retinopathy evaluations, leading to a risk of preventable blindness. This lack of evaluation contributes to care gaps for health plans and healthcare providers.
Solution
EyeCheq provides an intuitive screening kiosk that performs diabetic retinopathy screenings and other visual assessments. Retinal pictures are reviewed by an EyeCheq doctor to detect signs of health conditions like diabetes and high blood pressure.
Why now
There is a significant unmet need for accessible and convenient diabetic retinopathy screenings and general eye health assessments, especially with a large population at risk for preventable blindness and health issues. Technology allows for automated, easy-to-deploy screening solutions.
Verdict
This cleared because it presented a practical, deployable solution to an established healthcare gap, not because it promised novel medical breakthroughs. Investors implicitly bet on the operational efficiency gains and cost savings for health plans and providers by decentralizing a critical, but often missed, screening. Upside was limited by the specialized nature of diabetic retinopathy screening, constraining the potential for broad, general diagnostic application beyond its core focus.
Source: SEC EDGAR Form D filing